JP2007521799A5 - - Google Patents

Download PDF

Info

Publication number
JP2007521799A5
JP2007521799A5 JP2006538755A JP2006538755A JP2007521799A5 JP 2007521799 A5 JP2007521799 A5 JP 2007521799A5 JP 2006538755 A JP2006538755 A JP 2006538755A JP 2006538755 A JP2006538755 A JP 2006538755A JP 2007521799 A5 JP2007521799 A5 JP 2007521799A5
Authority
JP
Japan
Prior art keywords
polypeptide
compound
gene expression
expression pattern
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006538755A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007521799A (ja
JP5118851B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/012572 external-priority patent/WO2005045044A2/en
Publication of JP2007521799A publication Critical patent/JP2007521799A/ja
Publication of JP2007521799A5 publication Critical patent/JP2007521799A5/ja
Application granted granted Critical
Publication of JP5118851B2 publication Critical patent/JP5118851B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006538755A 2003-11-07 2004-11-05 線維芽細胞増殖因子フラグメントの使用 Expired - Fee Related JP5118851B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US51807303P 2003-11-07 2003-11-07
US60/518,073 2003-11-07
US57224704P 2004-05-18 2004-05-18
US60/572,247 2004-05-18
PCT/EP2004/012572 WO2005045044A2 (en) 2003-11-07 2004-11-05 Use of fibroblast growth factor fragments

Publications (3)

Publication Number Publication Date
JP2007521799A JP2007521799A (ja) 2007-08-09
JP2007521799A5 true JP2007521799A5 (https=) 2007-12-13
JP5118851B2 JP5118851B2 (ja) 2013-01-16

Family

ID=34576820

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538755A Expired - Fee Related JP5118851B2 (ja) 2003-11-07 2004-11-05 線維芽細胞増殖因子フラグメントの使用

Country Status (7)

Country Link
US (3) US20090093398A1 (https=)
EP (1) EP1682665B1 (https=)
JP (1) JP5118851B2 (https=)
AT (1) ATE507296T1 (https=)
DE (1) DE602004032457D1 (https=)
ES (1) ES2365852T3 (https=)
WO (1) WO2005045044A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
JP2006347979A (ja) * 2005-06-17 2006-12-28 National Institute Of Advanced Industrial & Technology 創傷治療及び/又は創傷治癒促進のための薬剤
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
US11308462B2 (en) 2014-05-13 2022-04-19 Clear Token Inc Secure electronic payment
WO2016208776A1 (ja) 2015-06-25 2016-12-29 株式会社国際電気通信基礎技術研究所 多器官連関システムを基盤とした予測装置、及び予測プログラム
JP6432962B2 (ja) 2016-03-29 2018-12-05 株式会社国際電気通信基礎技術研究所 腎機能低下、慢性腎疾患及び腎不全からなる群から選択される少なくとも一種の疾患を予防、又は治療するための有効成分の候補物質のスクリーニング方法
EP3466446B1 (en) 2016-03-29 2023-12-27 Karydo Therapeutix, Inc. Pharmaceutical composition or food composition, and method for assessing effect of active ingredient in vivo
US20230025003A1 (en) * 2019-10-18 2023-01-26 BioZipcode, Inc. Diabetes therapy targeting abnormal stem cells
US20230382966A1 (en) * 2020-10-27 2023-11-30 Indiana University Research And Technology Corporation Novel klotho interaction site in the c-terminus of fgf23
CN114940990B (zh) * 2022-06-20 2023-03-14 北京市神经外科研究所 与颅内动脉瘤相关的基因突变位点及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001245535A1 (en) * 2000-03-08 2001-09-17 Chiron Corporation Human fgf-23 gene and gene expression products
WO2001066595A2 (en) * 2000-03-08 2001-09-13 Chiron Corporation Human fgf-23 gene and gene expression products
ATE461213T1 (de) * 2000-07-19 2010-04-15 Advanced Res & Tech Inst Neuer fibroblastwachstumsfaktor (fgf23) und methoden zur verwendung
AU2002214286A1 (en) * 2000-11-15 2002-05-27 Akiko Itai Method of profiling protein
JP2002223753A (ja) * 2001-01-30 2002-08-13 Hitachi Ltd 薬物応答解析用オリゴヌクレオチドアレイ
US20040171825A1 (en) * 2001-04-26 2004-09-02 Lydie Bougueleret Human fibroblast growth factor-related compositions
CA2480386A1 (en) * 2002-03-29 2003-10-09 National Institute Of Advanced Industrial Science And Technology Novel galactose transferases, peptides thereof and nucleic acid encoding the same
JPWO2003091427A1 (ja) * 2002-04-24 2005-09-02 関西ティー・エル・オー株式会社 近位尿細管に発現する腎疾患関連遺伝子群

Similar Documents

Publication Publication Date Title
Lagord et al. Expression of TGFβ2 but not TGFβ1 correlates with the deposition of scar tissue in the lesioned spinal cord
Fan et al. Rapid transport of insulin to the brain following intranasal administration in rats
JP2007521799A5 (https=)
Logan et al. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere
JP2003505075A5 (https=)
JP6921755B2 (ja) 脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物
Hao et al. The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats
Kwong et al. Chronic smoking enhances tachykinin synthesis and airway responsiveness in guinea pigs
JP2017501381A5 (https=)
CN111228464A (zh) 广谱抗冠状病毒的多肽及其用途
JP2001511456A (ja) 神経学的欠損を治療する方法
JP2006518991A5 (https=)
CN113667748A (zh) circIKBKB的抑制剂及其检测试剂在乳腺癌骨转移诊断、治疗和预后试剂盒的应用
CN110256574B (zh) 融合多肽及在制备抗抑郁、神经退行性疾病药物中的应用
AU2024201372A1 (en) Drug target of idiopathic pulmonary fibrosis
AU2002341938B2 (en) Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
AU2002341938A1 (en) Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
Yao et al. Suppression of asparaginyl endopeptidase attenuates breast cancer-induced bone pain through inhibition of neurotrophin receptors
CN107428811B (zh) 用于治疗和/或诊断阿尔茨海默氏痴呆症的特异性结合A-β-物类的肽
KR102146047B1 (ko) 종양 억제 유전자 pip4k2a 및 그의 용도
Nyström et al. The role of fibroblasts in dystrophic epidermolysis bullosa pathogenesis and current treatment approaches
Grandis et al. The role of peptide growth factors in head and neck carcinoma
CN111139299B (zh) Josd2蛋白在制备治疗恶性肿瘤药物中的应用
JP2004533235A5 (https=)
Peng et al. Mechanisms by which spinal cord stimulation intervenes in atrial fibrillation: The involvement of the endothelin-1 and nerve growth factor/p75NTR pathways